Gilead's Kite files for FDA approval of second CAR-T therapy

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 12, 2019 at 11:42 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,746
    Likes Received:
    3
    via Gilead’s Kite has filed for FDA approval of its second CAR-T cell therapy. Kite hopes to win approval for KTE-X19 in mantle cell lymphoma on the strength of midphase results linking it to a 67% complete response rate.

    article source